Clinical trial
Deoxycholic Acid Injection for the Treatment of Superficial Lipomas
NCT00422188 · Kythera Biopharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00422188 |
|---|---|
| Title | Deoxycholic Acid Injection for the Treatment of Superficial Lipomas |
| Official title | Phase 1, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Sequential Dose-Escalation Study of the Pharmacokinetics, Safety, and Efficacy of ATX-101 (Sodium Deoxycholate for Injection) Intralipomal Injections for the Treatment of Superficial Lipomas |
| Lead sponsor | Kythera Biopharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lipoma |
| Intervention type | Drug |
| Interventions | Deoxycholic Acid Injection, Placebo |
| Enrollment | 16 |
| Start date | Jan 1, 2007 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Jan 15, 2007 |
| Last update posted | Dec 10, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: